ABC Arbitrage’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAM
ABC Arbitrage's RNAM Position: Q1 2026 in Review
ABC Arbitrage sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 93,300 shares — an estimated $6.73M sold.
ABC Arbitrage first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $6.73M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- ABC Arbitrage reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- ABC Arbitrage sold 93,300 Avidity Biosciences shares in Q1 2026, an estimated $6.73M.
- ABC Arbitrage first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
- ABC Arbitrage's Avidity Biosciences position peaked at $6.73M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on ABC Arbitrage's 13F filing for Q1 2026, filed 4 May 2026.